It’s not a simplistic view at all.
One case study, as in this case, is a very low value form of evidence. We refer to it in medicine, as an ‘n of one study’ (the n being the number of participating subjects in the study)
A case study is an ‘easy-out’ for a training doctor or a less-than-enthusiastic researcher, to get published.
A properly constructed, blinded RCT, with excellent results, is needed for the big end to swoop in.
Company mis-guidance and funny buggers., page-31
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.002(5.41%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 4.0¢ | 3.5¢ | $1.163M | 31.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 2275218 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 196677 | 3 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
